Zhan Xiaohui, Jiang Yujia, Lei Jiahui, Chen Hao, Liu Tangyuheng, Lan Fang, Ying Binwu, Wu Yao
National Engineering Research Center for Biomaterials, Sichuan University, Chengdu 610064, People's Republic of China.
Department of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu 610041, People's Republic of China.
J Colloid Interface Sci. 2025 Apr;683(Pt 2):521-531. doi: 10.1016/j.jcis.2024.12.182. Epub 2024 Dec 24.
CRISPR-Cas-based technology, emerging as a leading platform for molecular assays, has been extensively researched and applied in bioanalysis. However, achieving simultaneous and highly sensitive detection of multiple nucleic acid targets remains a significant challenge for most current CRISPR-Cas systems. Herein, a CRISPR Cas12a based calibratable single particle counting-mediated biosensor was constructed for dual RNAs logic and ultra-sensitive detection in one tube based on DNA Tetrahedron (DTN)-interface supported fluorescent particle probes coupled with a novel synergistic cascaded strategy between CRISPR Cas13a system and strand displacement amplification (SDA). As expected, our platform enables dual RNA molecules intelligent detection using only one crRNA of Cas13a, achieving a sensitivity enhancement of three orders of magnitude assisted with multiple signal amplification and accurate fluorescence particle counting with DTN mediated nano-biointerface enhancement, compared to traditional bulk Cas13a assays. Moreover, the effectiveness and universality of our strategy are experimentally investigated and demonstrated through the detection of mRNAs (cervical cancer swab clinical samples and cultured cancer cells) and bacterial 16s rRNAs. This work not only proposes a highly promising avenue for designing CRISPR-based multiplex detection systems that excel in ultra-sensitivity, specificity, and clinical molecular diagnostics, but also provide new insights into the potential applications of nanotechnology in molecular diagnostics, functional surface engineering, and interface-mediated bioreactions.
基于CRISPR-Cas的技术作为分子检测的领先平台正在兴起,已在生物分析中得到广泛研究和应用。然而,对于大多数当前的CRISPR-Cas系统而言,实现对多个核酸靶标的同时且高灵敏度检测仍然是一项重大挑战。在此,构建了一种基于CRISPR Cas12a的可校准单粒子计数介导的生物传感器,用于基于DNA四面体(DTN)界面支持的荧光粒子探针,结合CRISPR Cas13a系统与链置换扩增(SDA)之间的新型协同级联策略,在一管中进行双RNA逻辑和超灵敏检测。正如预期的那样,我们的平台仅使用Cas13a的一种crRNA就能实现双RNA分子的智能检测,与传统的整体Cas13a检测相比,通过多重信号放大和DTN介导的纳米生物界面增强实现的精确荧光粒子计数,灵敏度提高了三个数量级。此外,通过检测mRNA(宫颈癌拭子临床样本和培养的癌细胞)和细菌16s rRNA,对我们策略的有效性和通用性进行了实验研究和验证。这项工作不仅为设计在超灵敏度、特异性和临床分子诊断方面表现出色的基于CRISPR的多重检测系统提出了一条极有前景的途径,还为纳米技术在分子诊断、功能表面工程和界面介导的生物反应中的潜在应用提供了新的见解。